Ingredient
Nonoxynol-20
Nonoxynol-20 is flagged for pregnancy, breastfeeding, trying to conceive, PCOS, postpartum and general use. The concern behind the strongest flag is endocrine disruptor and absorbed into the body.
- Polyoxyethylene (20) Nonyl Phenyl Ether
- POE (20) Nonyl Phenyl Ether
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Nonoxynol-20 and pregnancy
Not Recommended
- Endocrine disruptor
- Absorbed into the body
- Fetal development
Nonoxynol-20 is an ethoxylated compound used as an emulsifier in cosmetics. It belongs to a chemical family that has raised concerns among regulatory agencies for its potential hormonal effects. The European Chemicals Agency (ECHA) has classified nonylphenol ethoxylates as substances of very high concern due to their endocrine-disrupting properties. These compounds can break down into nonylphenol, which mimics estrogen in the body. While specific pregnancy studies on topical nonoxynol-20 are limited, the potential for hormone disruption during critical fetal development periods makes this ingredient concerning. Most obstetricians recommend avoiding ingredients with known endocrine-disrupting potential throughout pregnancy. The EU Cosmetics Regulation restricts the use of nonoxynol compounds, and many dermatologists advise pregnant women to choose products without these ingredients. Given the availability of safer emulsifiers and the precautionary principle, avoiding nonoxynol-20 during pregnancy is prudent.
Nonoxynol-20 and breastfeeding
Not Recommended
- Endocrine disruptor
- Passes into breast milk
- Infant exposure
Nonoxynol-20 is a synthetic emulsifier that can be absorbed through the skin. Its chemical structure allows it to penetrate biological membranes, raising concerns about transfer into breast milk. While specific studies on nonoxynol-20 transfer to breast milk are lacking, compounds in this family have demonstrated estrogenic activity. The infant endocrine system is particularly vulnerable to disruption, and exposure through breast milk could theoretically affect hormone-dependent development. Most pediatricians and lactation consultants recommend avoiding ingredients with endocrine-disrupting potential during breastfeeding. Given the ECHA classification of related compounds as substances of very high concern and the availability of safer emulsifiers, breastfeeding women should choose products without nonoxynol compounds. The American Academy of Pediatrics emphasizes minimizing infant exposure to endocrine disruptors during critical developmental periods.
Nonoxynol-20 and postpartum
Caution Advised
- Endocrine disruptor
- Irritant
Nonoxynol-20 functions as an emulsifier in cosmetic products. For postpartum women not breastfeeding, the primary concerns relate to its endocrine-disrupting potential and skin irritation, particularly on sensitive postpartum skin. The European Union has restricted nonoxynol compounds due to hormonal concerns, though the risk is lower when not pregnant or breastfeeding. Women recovering from childbirth may have more sensitive skin that could react to this ingredient. Choosing products with gentler, non-endocrine-disrupting emulsifiers is generally advisable during the postpartum recovery period.
Nonoxynol-20 and trying to conceive
Not Recommended
- Hormone disruptor
- Fertility effects
- Builds up in tissue
Nonoxynol-20 belongs to a family of compounds known for endocrine-disrupting properties. Women trying to conceive should optimize their hormonal environment, making exposure to hormone-disrupting chemicals particularly undesirable. The ECHA classification of nonylphenol ethoxylates as substances of very high concern includes reproductive toxicity concerns. These compounds can accumulate in fatty tissues and persist in the body. Most fertility specialists recommend minimizing exposure to endocrine disruptors during the preconception period, as hormonal balance is crucial for conception and early embryonic development. Switching to products without nonoxynol compounds before actively trying to conceive allows time for any accumulated compounds to clear.
Nonoxynol-20 and PCOS
Not Recommended
- Interferes with hormones
- Affects estrogen
- Mimics androgens
Nonoxynol-20 is an emulsifier with documented estrogenic activity. Women with PCOS already have hormonal imbalances, primarily involving elevated androgens and insulin resistance, making exposure to endocrine-disrupting chemicals particularly concerning. ECHA has identified nonylphenol ethoxylates as endocrine disruptors that can interfere with normal hormonal signaling. For women with PCOS, who are managing hormone-sensitive conditions, introducing ingredients that mimic or disrupt estrogen could theoretically worsen hormonal imbalances. While topical exposure is lower than oral intake, the cumulative effect of endocrine disruptors in personal care products is a growing concern. Many endocrinologists and reproductive specialists recommend that women with PCOS minimize exposure to known endocrine disruptors. The EU restriction on these compounds reflects serious regulatory concern. Choosing products with safer emulsifiers can help reduce overall endocrine disruptor burden.
Nonoxynol-20 and general use
Caution Advised
- Endocrine disruptor
- Common allergen
- Irritant
Nonoxynol-20 is a synthetic emulsifier used to blend oil and water phases in cosmetic formulations. It's part of the nonoxynol family, which includes compounds used in various applications from cosmetics to industrial cleaners. The European Union has restricted nonoxynol compounds due to concerns about endocrine disruption and environmental persistence. ECHA has classified nonylphenol ethoxylates as substances of very high concern, noting their ability to interfere with hormone systems and their persistence in the environment. Some individuals also experience allergic contact dermatitis from these compounds. While the risk from cosmetic use is generally lower than environmental or occupational exposure, cumulative exposure from multiple products is a consideration. Many dermatologists recommend choosing products with alternative emulsifiers that don't carry endocrine-disrupting concerns. The EU restriction reflects serious regulatory concern about this ingredient class, though it remains legal in some concentrations and applications. For those concerned about hormone health or environmental impact, avoiding nonoxynol compounds is advisable.
Everything else flagged for the same profiles
Related ingredients
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store